CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Shares withheld for taxes EVP Prod Dev & Med Aff & CMO gave up 27,224 shares (to pay taxes)
- 4 Planned sale CSO/EVP Disc & Trans Research sold 96,986 shares at $35.00 ($3,394,510)
- 4 Planned sale EVP & General Counsel sold 50,000 shares at $34.13 ($1,706,500)
- 4 Open-market sale Director sold 30,000 shares at $34.00 ($1,020,000)
- 4 Gift President and CEO gave 46,000 shares (gift)
- 4 Planned sale CSO/EVP Disc & Trans Research sold 1,162 shares at $31.40 ($36,487)
- 4 Planned sale EVP & General Counsel sold 25,000 shares at $28.39 ($709,750)
- 4 Shares withheld for taxes EVP, Commercial gave up 96,111 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 463,702 shares (to pay taxes)
- 4 Planned sale EVP & General Counsel sold 25,000 shares at $26.38 ($659,500)
- 4 Planned sale EVP, General Counsel & Sec sold 20,000 shares at $25.79 ($515,800)
- 4 Open-market sale Director sold 8,250 shares at $26.56 ($219,120)
- 4 Other disposition Director disposed of 4,682 shares (other)
- 4 Open-market sale CSO/EVP Disc & Trans Research sold 20,883 shares at $27.06 ($565,094)
- 4 Open-market sale Director sold 33,725 shares at $26.89 ($906,865)
- 4 Planned sale CSO/EVP Disc & Trans Research sold 95,000 shares at $25.00 ($2,375,000)
- 4 Planned sale EVP, Commercial sold 14,000 shares at $25.50 ($357,000)
- 4 Planned sale EVP, General Counsel & Sec sold 80,000 shares at $25.97 ($2,077,600)
- 4 Open-market sale EVP and CFO sold 125,000 shares at $27.19 ($3,398,750)
- 4 Planned sale Director sold 8,287 shares at $22.00 ($182,314)
Page 7 of 73 · 1,458 filings